Abstract
A total of 32 evaluable patients with measurable advanced colorectal carcinoma were treated with continuous-infusion alpha-difluoromethylornithine (DFMO) at a median daily dose of 8 g/m2 (range, 6-14 g/m2). DFMO was infused over 24 h daily for 28 days, followed by a rest period of 7 days. Of the 32 patients, 14 had received no prior chemotherapy. A total of 65 courses was given, with the median being 2 (range, 1-9 courses). None of the patients achieved a partial or complete response; however, 3 patients achieved a minor response and 14 had stable disease. The frequent toxic effects of DFMO included thrombocytopenia (which was dose-limiting), malaise, nausea, vomiting, reversible hearing loss, and diarrhea. Our data suggest that continuous-infusion DFMO therapy is feasible and results in only mild gastrointestinal toxicity. Although DFMO proved to be ineffective as a single agent in this trial, it could probably best be used in combination with cytotoxic agents known to enhance its antitumor activity in a preclinical setting.
References
Jan 1, 1979·Perspectives in Biology and Medicine·H G Williams-Ashman, Z N Canellakis
Mar 15, 1978·Biochemical and Biophysical Research Communications·P S MamontP Bey
Jan 28, 1986·Biochemistry·A E PeggB G Erwin
Jan 1, 1986·European Journal of Cancer & Clinical Oncology·T A Splinter, J C Romijn
Mar 1, 1986·The Biochemical Journal·A E Pegg
Jan 1, 1985·Investigational New Drugs·A M MaddoxE J Freireich
Jan 1, 1984·Annual Review of Biochemistry·C W Tabor, H Tabor
Apr 1, 1981·Proceedings of the National Academy of Sciences of the United States of America·G D LukS B Baylin
Jan 1, 1983·Cancer Chemotherapy and Pharmacology·R P WarrellJ H Burchenal
Mar 15, 1984·Cancer·H W HerrW F Whitmore
Mar 1, 1984·Clinical Pharmacology and Therapeutics·A Sjoerdsma, P J Schechter
Feb 1, 1984·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·M D AbeloffS B Baylin
Aug 1, 1984·European Journal of Biochemistry·P S MamontP Casara
Jul 16, 1980·Biochemical and Biophysical Research Communications·P S SunkaraP N Rao
Jan 1, 1981·Experimental Cell Research·J SeidenfeldL J Marton
Nov 1, 1982·The American Journal of Physiology·A E Pegg, P P McCann
Citations
Jan 1, 1992·Pharmacology & Therapeutics·P P McCann, A E Pegg
May 19, 2001·The Laryngoscope·K J Doyle
Jan 1, 2003·The Surgical Clinics of North America·Ernest T HawkJaye L Viner
May 27, 2005·World Journal of Gastroenterology : WJG·Takahiro NemotoDaijo Hashimoto
Jan 25, 2002·Annals of the New York Academy of Sciences·A UmarE T Hawk
Sep 12, 2020·Technology in Cancer Research & Treatment·Mahmoud AlhosinHani Choudhry